Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
D010146 | Pain NIH | 0.71 |
D003929 | Diabetic Neuropathies NIH | 0.71 |
D010523 | Peripheral Nervous System Diseases NIH | 0.58 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0012531 | Pain HPO | 0.71 |
HP:0001271 | Polyneuropathy HPO | 0.58 |
Navigate: Correlations HPO
There is one clinical trial.
This is a randomized, double-blind, 2-arm, parallel group study of up to 274 evaluable patients designed to evaluate the safety and efficacy of the histone deacetylase 6 (HDAC6) inhibitor ricolinostat for painful DPN.
Description: Difference between mean average pain intensity
Measure: Mean Average Pain Intensity (NRS) Time: Baseline week [Day-7 to Day 1] compared to Final week [12 Weeks]Description: Difference between mean average pain intensity
Measure: Mean Average Pain Intensity (NRS) Time: Baseline week [Day-7 to Day 1] compared to Week 4Description: Change in non-pain neuropathic signs
Measure: Non-pain Neuropathic Signs (UENS) Time: Baseline week [Day-7 to Day 1] compared to Week 12Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports